These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Generation of a reassortant avian influenza virus H5N2 vaccine strain capable of protecting chickens against infection with Egyptian H5N1 and H9N2 viruses. Kandeil A, Moatasim Y, Gomaa MR, Shehata MM, El-Shesheny R, Barakat A, Webby RJ, Ali MA, Kayali G. Vaccine; 2016 Jan 04; 34(2):218-224. PubMed ID: 26620838 [Abstract] [Full Text] [Related]
5. Characterization of reverse genetics-derived cold-adapted master donor virus A/Leningrad/134/17/57 (H2N2) and reassortants with H5N1 surface genes in a mouse model. Isakova-Sivak I, Chen LM, Bourgeois M, Matsuoka Y, Voeten JT, Heldens JG, van den Bosch H, Klimov A, Rudenko L, Cox NJ, Donis RO. Clin Vaccine Immunol; 2014 May 04; 21(5):722-31. PubMed ID: 24648485 [Abstract] [Full Text] [Related]
6. Improvement of H5N1 influenza vaccine viruses: influence of internal gene segments of avian and human origin on production and hemagglutinin content. Abt M, de Jonge J, Laue M, Wolff T. Vaccine; 2011 Jul 18; 29(32):5153-62. PubMed ID: 21624413 [Abstract] [Full Text] [Related]
7. Generation of an attenuated H5N1 avian influenza virus vaccine with all eight genes from avian viruses. Shi H, Liu XF, Zhang X, Chen S, Sun L, Lu J. Vaccine; 2007 Oct 16; 25(42):7379-84. PubMed ID: 17870216 [Abstract] [Full Text] [Related]
11. Optimized clade 2.3.2.1c H5N1 recombinant-vaccine strains against highly pathogenic avian influenza. Jang JW, Lee CY, Kim IH, Choi JG, Lee YJ, Yuk SS, Lee JH, Song CS, Kim JH, Kwon HJ. J Vet Sci; 2017 Aug 31; 18(S1):299-306. PubMed ID: 28859269 [Abstract] [Full Text] [Related]
12. Improvement of influenza vaccine strain A/Vietnam/1194/2004 (H5N1) growth with the neuraminidase packaging sequence from A/Puerto Rico/8/34. Pan W, Dong Z, Meng W, Zhang W, Li T, Li C, Zhang B, Chen L. Hum Vaccin Immunother; 2012 Feb 31; 8(2):252-9. PubMed ID: 22426370 [Abstract] [Full Text] [Related]
13. Recombinant parainfluenza virus 5 expressing clade 2.3.4.4b H5 hemagglutinin protein confers broad protection against H5Ny influenza viruses. Li H, Sun H, Tao M, Han Q, Yu H, Li J, Lu X, Tong Q, Pu J, Sun Y, Liu L, Liu J, Sun H. J Virol; 2024 Mar 19; 98(3):e0112923. PubMed ID: 38305155 [Abstract] [Full Text] [Related]
14. Live attenuated influenza viruses containing NS1 truncations as vaccine candidates against H5N1 highly pathogenic avian influenza. Steel J, Lowen AC, Pena L, Angel M, Solórzano A, Albrecht R, Perez DR, García-Sastre A, Palese P. J Virol; 2009 Feb 19; 83(4):1742-53. PubMed ID: 19073731 [Abstract] [Full Text] [Related]
15. Stockpiled pre-pandemic H5N1 influenza virus vaccines with AS03 adjuvant provide cross-protection from H5N2 clade 2.3.4.4 virus challenge in ferrets. Sun X, Belser JA, Pulit-Penaloza JA, Creager HM, Guo Z, Jefferson SN, Liu F, York IA, Stevens J, Maines TR, Jernigan DB, Katz JM, Levine MZ, Tumpey TM. Virology; 2017 Aug 19; 508():164-169. PubMed ID: 28554058 [Abstract] [Full Text] [Related]
18. Efficacy of single dose of a bivalent vaccine containing inactivated Newcastle disease virus and reassortant highly pathogenic avian influenza H5N1 virus against lethal HPAI and NDV infection in chickens. Lee DH, Park JK, Kwon JH, Yuk SS, Erdene-Ochir TO, Jang YH, Seong BL, Lee JB, Park SY, Choi IS, Song CS. PLoS One; 2013 Aug 19; 8(3):e58186. PubMed ID: 23469269 [Abstract] [Full Text] [Related]